Abbott CEO Says the Libre Story Just Keeps Getting Better

It's been about four months since FDA approved Abbott's FreeStyle Libre Flash glucose monitoring system as a replacement for blood glucose monitoring (BGM) for adults and it's safe to say the Libre system has been a blockbuster product for the company. "First of all, it's going extremely well," CEO Miles White said during the company's fourth-quarter earnings call Wednesday, as transcribed by Seeking Alpha. "We did add 300,000 patients last quarter. That's almost equivalent to the entire u...

from A via a.sfakia on Inoreader http://bit.ly/2UlU6K5